Healthcare Equipment and Supplies
Company Overview of Arch Therapeutics, Inc.
Arch Therapeutics, Inc., operates as a biotechnology company in the United States. The company develops products based on its technology to stop bleeding and control leaking, as well as provides other advantages during surgery, trauma, and interventional care. Its primary product candidate is AC5 Devices, a synthetic biocompatible peptides that comprises naturally occurring amino acids to achieve hemostasis in minimally invasive and open surgical procedures. The company was founded in 2006 and is based in Framingham, Massachusetts.
235 Walnut Street
Framingham, MA 01702
Founded in 2006
Key Executives for Arch Therapeutics, Inc.
Arch Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems Inc.||United States|
|20/20 Imaging LLC||United States|
|206 Ortho, Inc.||United States|
|21st Century Scientific, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Arch Therapeutics, Inc., please visit www.archtherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.